
Sorbax Pharmaceuticals Private Limited
Pharmaceutical company specializing in manufacturing, trading, and exporting pharmaceutical products and ingredients.
Pharmaceutical company specializing in manufacturing, trading, and exporting pharmaceutical products and ingredients.
Sorbax Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2020 (Four years and six months 21 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.05 Cr. The company has closed loans amounting to ₹4.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Lalan Singh, Kota Prabhu, Dheeraj Shetty, and One other member serve as directors at the Company.
Solan, Himachal Pradesh, India
+91-XXXXXXXXXX
U24290HP2020PTC008140
008140
Private Limited Indian Non-Government Company
15 Oct 2020
30 Sep 2023
31 Mar 2023
Unlisted
Roc Himachal Pradesh
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lalan Singh ![]() | Director | 15-Oct-2020 | Current |
Kota Prabhu ![]() | Director | 15-Oct-2020 | Current |
Dheeraj Shetty ![]() | Director | 24-Feb-2021 | Current |
Manjeet Kaur ![]() | Additional Director | 04-May-2024 | Current |
Sorbax Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11661.87% increase. The company also saw a substantial improvement in profitability, with a 108.11% increase in profit. The company's net worth Soared by an impressive increase of 171.45%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Sorbax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Kota Prabhu is a mutual person
Dheeraj Shetty is a mutual person
₹5.05 Cr
₹4.04 Cr
Date | Lender | Amount | Status |
---|---|---|---|
27 Mar 2023 | Others | ₹5.05 Cr | Open |
13 Jul 2021 | Karnataka Bank Ltd. | ₹4.04 Cr | Satisfied |
Unlock and access historical data on people associated with Sorbax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sorbax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sorbax Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Manjeet Kaur was appointed as a Additional Director was appointed as a Additional Director on 04 May 2024 & has been associated with this company since 1 year 1 day .
Sorbax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
A charge registered on 13 Jul 2021 via Charge ID 100467096 with Karnataka Bank Ltd. was fully satisfied on 10 May 2023.
Sorbax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Himachal Pradesh.
A charge with Others amounted to Rs. 5.05 Cr with Charge ID 100734512 was registered on 27 Mar 2023.
A charge with Karnataka Bank Ltd. amounted to Rs. 4.04 Cr with Charge ID 100467096 was registered on 13 Jul 2021.
Sorbax Pharmaceuticals Private Limited was incorporated on 15 Oct 2020.
The authorized share capital of Sorbax Pharmaceuticals Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 1.00 Cr.
Currently 4 directors are associated with Sorbax Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sorbax Pharmaceuticals Private Limited is Plot No.112-A Hpsidc Industrial Estate Davni Teh., Distt. Solan India, Baddi, Himachal Pradesh, 173205.
The corporate identification number (CIN) of Sorbax Pharmaceuticals Private Limited is U24290HP2020PTC008140 and the company number is 008140 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Sorbax Pharmaceuticals Private Limited has risen by 11661.87%.
The financial reports for the fiscal year 2023 indicates that The net worth of Sorbax Pharmaceuticals Private Limited has experienced an upsurge of 171.45%.
As per the financial statements for fiscal Year 2023, The total open charges for Sorbax Pharmaceuticals Private Limited amount to ₹ 5.05 Cr.
The most recent Balance Sheet for Sorbax Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
KR